You must have an order with a minimum of $150.00 to place your order, your current order total is $0.00.
Peptide Education, Product Pillars, Research Protocols
MOTS-c: Complete Research Guide to the Mitochondrial-Derived Peptide
22
May
May
Research Use Only Notice: MOTS-c is a research peptide intended for in-vitro and animal research applications only. It is not FDA-approved as a drug or therapy. Nothing in this article constitutes medical advice, treatment recommendation, or guidance for human consumption.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide that has become a focal compound in modern metabolic and longevity research. Unlike most synthetic research peptides, MOTS-c is encoded by mitochondrial DNA rather than nuclear DNA — making it one of a small group of “mitochondrial-derived peptides” (MDPs) discovered relatively recently. Research has documented MOTS-c influencing insulin sensitivity, mitochondrial biogenesis, exercise-mimetic effects, and metabolic biomarker panels in animal models. This complete guide from the chemistry team at OPS Peptide Science walks through what MOTS-c is, how the mitochondrial-origin mechanism works, and where it sits in the broader research catalog.
For the foundational research-workflow protocols, see our companion guides on how to reconstitute peptides, how to inject peptides, and peptide storage and refrigeration.
What Is MOTS-c?
MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA-c) is a 16-amino-acid peptide encoded within the human mitochondrial 12S rRNA gene. The mitochondrial origin is biologically unusual — most peptides studied in research are encoded by nuclear DNA, while MOTS-c emerges from the small genome that mitochondria carry as a relic of their evolutionary origin as separate organisms.
Key facts about MOTS-c:
- Chemical class — 16-amino-acid mitochondrial-derived peptide (MDP)
- Molecular weight — approximately 2174 Da
- Source — encoded by mitochondrial DNA (12S rRNA region), not nuclear DNA
- Sequence — Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR)
- Form — typically supplied as lyophilized powder; reconstituted with bacteriostatic water
- Half-life — relatively short; research models use frequent dosing
- Stability — stable at -20°C as lyophilized powder for 18-24 months
The mitochondrial origin makes MOTS-c part of a small but growing class of research compounds — mitochondrial-derived peptides (MDPs). Other MDPs include humanin and the SHLP (small humanin-like peptide) family. MOTS-c is the most-studied of this group due to its metabolic effects.
MOTS-c Structure and Chemistry
MOTS-c’s structure is unusual for a peptide research compound:
- 16 amino acids — small enough for synthetic production at high purity
- Encoded by mitochondrial 12S rRNA — an unusual coding location for a functional peptide
- Naturally produced — research has documented endogenous MOTS-c in human and animal tissues, particularly in muscle
- Levels respond to exercise — published research has measured MOTS-c rising with exercise, supporting the “exercise-mimetic” research framing
- Levels decline with age — like many bioactive peptides, MOTS-c concentrations decrease in older subjects
The age-related decline and exercise-induced increase are what make MOTS-c interesting as a research target — both findings suggest MOTS-c is part of the cellular machinery that responds to metabolic stress and aging. Studying exogenous MOTS-c administration probes whether supplementing the natural decline produces measurable effects on the same pathways.
How MOTS-c Works in Research (Mechanism)
The MOTS-c mechanism is one of the better-characterized in modern research peptide science. Documented pathways include:
- AMPK activation — MOTS-c activates AMP-activated protein kinase, a central cellular energy sensor that regulates metabolism
- Folate-methionine cycle modulation — research has documented effects on one-carbon metabolism, which sits upstream of multiple cellular pathways
- Mitochondrial biogenesis — induces new mitochondrial formation in research models, increasing cellular mitochondrial density
- Glucose homeostasis — improves insulin sensitivity and glucose disposal in animal research models
- Skeletal muscle metabolism — particularly active in muscle tissue, where MOTS-c affects glucose uptake and fatty acid oxidation
- Mitochondrial-nuclear signaling — MOTS-c travels from mitochondria to nucleus, where it influences gene expression
The AMPK activation mechanism positions MOTS-c alongside compounds like metformin in mechanistic research — both activate AMPK, though through different upstream signals. The mitochondrial-nuclear signaling component is particularly novel for research peptides — MOTS-c demonstrates that mitochondria don’t just produce energy; they also send signaling molecules that influence nuclear gene expression. The published MOTS-c research literature on PubMed documents these mechanisms across the past decade of investigation.
MOTS-c Research Applications
Metabolic Research
The largest body of MOTS-c research focuses on metabolic endpoints — insulin sensitivity, glucose tolerance, lipid profiles, and broader metabolic biomarker panels. Animal models studying type 2 diabetes biology, metabolic syndrome research, and obesity-related metabolic disorders have produced consistent MOTS-c data across multiple studies.
Exercise-Mimetic Research
Because endogenous MOTS-c rises with exercise, the compound has been studied as a potential “exercise mimetic” — producing some of exercise’s metabolic effects without physical activity. Research models have documented MOTS-c effects on muscle glucose uptake, mitochondrial biogenesis, and aerobic capacity markers that overlap with exercise adaptations.
Mitochondrial Biology Research
MOTS-c is one of the central research compounds in mitochondrial biology — investigating mitochondrial-nuclear communication, mitochondrial biogenesis pathways, and mitochondrial dysfunction in aging and disease models. The compound’s mitochondrial origin makes it uniquely positioned as a research probe for mitochondrial signaling.
Aging and Longevity Research
The age-related decline in endogenous MOTS-c has driven longevity research applications. Studies have measured effects on aging-related biomarkers, healthspan endpoints, and mitochondrial function across age cohorts in animal models. MOTS-c sits alongside SS-31, NAD+ precursors, and other mitochondrial compounds in the longevity research portfolio.
Bone Research
Emerging research area — MOTS-c has been documented in bone biology research models, with effects on osteoblast activity and bone density markers. This area is smaller than the metabolic research but growing.
MOTS-c Dosing in Research Models
Research dosing patterns for MOTS-c in published studies:
- Subcutaneous or intraperitoneal injection — both routes appear in published animal research
- Daily dosing common — short half-life supports daily administration in most protocols
- Cycle-based protocols — some research designs use 4-12 week dosing cycles with washout periods
- Dose amounts — typically reported in mg/kg body weight in animal research; specific protocols vary by species and endpoint
- Endpoint timelines — metabolic endpoints typically measured at 4-8 weeks; longevity endpoints over longer durations
Research protocols should reference published methodology for the specific research model. The acute vs. cumulative effect timeline distinction is addressed in our guide on how long does it take for peptides to work.
MOTS-c Storage and Stability
MOTS-c stability is comparable to other small lyophilized research peptides:
| Storage Condition | Form | Stability Window |
|---|---|---|
| -80°C | Lyophilized powder | 3-5+ years |
| -20°C | Lyophilized powder | 18-24 months |
| 2-8°C | Lyophilized powder | 6-12 months |
| 2-8°C | Reconstituted in BAC water | 21-28 days |
| Room temperature | Lyophilized powder | 2-4 weeks for transit |
For practical storage protocols, see our guide on how long do peptides last at room temperature.
MOTS-c vs SS-31 and Other Mitochondrial Compounds
Several research compounds target mitochondrial biology. Brief comparison:
| Compound | Type | Mechanism | Primary Research Focus |
|---|---|---|---|
| MOTS-c | Mitochondrial-derived peptide | AMPK activation, gene expression | Metabolism, insulin sensitivity, exercise mimicry |
| SS-31 (elamipretide) | Synthetic peptide | Cardiolipin binding, membrane stabilization | Cardiac, neurodegeneration, mitochondrial membrane |
| Humanin | Mitochondrial-derived peptide | Anti-apoptotic, cytoprotective | Neurodegeneration, cell survival |
| NAD+ precursors | Small molecule | NAD+ pool expansion | Sirtuin activation, aging biology |
MOTS-c and SS-31 are the two most-cited mitochondrial peptides in modern research. They address different aspects of mitochondrial biology — MOTS-c affects gene expression and metabolic signaling, SS-31 stabilizes the inner mitochondrial membrane. Many research designs use them in parallel rather than as alternatives.
How to Identify Quality Research-Grade MOTS-c
Quality criteria for research-grade MOTS-c:
- 99%+ HPLC-MS verified purity — small peptide synthesis is generally manageable, but verification is essential for reproducible research
- Per-lot Certificate of Analysis — each batch independently tested
- Mass spectrometry identity confirmation — confirms molecular weight matches MOTS-c (~2174 Da)
- Chain-of-custody documentation — traceable from manufacturer through fulfillment
- Properly lyophilized appearance — clean white cake at the bottom of the vial
- Research-use-only labeling — required by US regulations
At OPS Peptide Science, every MOTS-c vial ships with a unique BIOVIRIDIAN COA code. Customers can verify the Certificate of Analysis for their specific lot — confirming purity and identity before opening the vial.
MOTS-c Regulatory Status
MOTS-c sits in standard research-peptide regulatory territory:
- Not FDA-approved — has not completed clinical trials required for human drug approval
- Legal as research chemical — sold in the US for in-vitro and animal research under research-use-only labeling
- Not WADA-prohibited — as of current updates, MOTS-c is not on the WADA Prohibited List, though this could change with future updates
- Not DEA-scheduled — no controlled substance status
- Newer compound — discovered around 2015, so regulatory frameworks are still adapting
For the complete legal framework around research peptides, see our detailed guide on are peptides illegal. According to NIH research literature, MOTS-c remains an active area of pre-clinical investigation, particularly in metabolic and longevity contexts.
FAQ
What is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA (specifically the 12S rRNA gene). It is one of a small class of “mitochondrial-derived peptides” (MDPs). Research has documented effects on insulin sensitivity, mitochondrial biogenesis, AMPK activation, and metabolic biomarker panels across animal research models.
What makes MOTS-c different from other peptides?
Two things. First, MOTS-c is encoded by mitochondrial DNA rather than nuclear DNA — unusual for a peptide. Second, MOTS-c demonstrates mitochondrial-nuclear signaling, where mitochondria send a peptide that influences nuclear gene expression. These features make MOTS-c a unique research probe for mitochondrial biology.
How does MOTS-c work?
MOTS-c activates AMP-activated protein kinase (AMPK), a central cellular energy sensor. AMPK activation produces downstream effects on glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and metabolic gene expression. MOTS-c also modulates folate-methionine cycle activity and travels from mitochondria to nucleus to influence gene expression directly.
Is MOTS-c an exercise mimetic?
Some research uses this framing because endogenous MOTS-c levels rise with exercise. Animal research has documented overlap between MOTS-c administration and exercise-induced adaptations — muscle glucose uptake, mitochondrial biogenesis, aerobic capacity markers. This doesn’t mean MOTS-c replaces exercise; it suggests both engage similar metabolic pathways.
What’s the difference between MOTS-c and SS-31?
Both target mitochondria but through different mechanisms. MOTS-c is mitochondrial-encoded and acts through AMPK and gene expression. SS-31 is a synthetic peptide that binds cardiolipin in the mitochondrial membrane, providing structural stabilization. Research often uses them as complementary tools — MOTS-c for signaling/metabolic endpoints, SS-31 for membrane and bioenergetics endpoints.
Is MOTS-c legal in the US?
Yes — MOTS-c is legally sold in the US as a research chemical for in-vitro and animal research under research-use-only labeling. It is not FDA-approved and is not currently on the WADA Prohibited List. See our detailed guide on are peptides illegal for the full framework.
Where can I buy research-grade MOTS-c?
Research-grade MOTS-c is sold by research peptide suppliers operating under research-use-only labeling. Quality criteria include 99%+ HPLC-MS verified purity, per-lot Certificates of Analysis, mass spectrometry identity confirmation, and traceable chain-of-custody. Browse the OPS Peptide Science catalog for verified research-grade MOTS-c.
MOTS-c represents a new class of research peptides — mitochondrial-derived peptides that demonstrate mitochondria-nuclear signaling. The AMPK activation mechanism, exercise-mimetic profile, and metabolic effects make MOTS-c one of the most cited compounds in modern metabolic and longevity research. For researchers studying mitochondrial biology, insulin sensitivity, or aging endpoints, MOTS-c is among the most-referenced peptides in the modern research catalog.
For research-grade MOTS-c backed by per-lot Certificates of Analysis and full HPLC-MS purity documentation, browse the OPS Peptide Science catalog, visit the OPS Peptide Science homepage for the full product overview, or verify a specific lot using its COA code.
Author: Shane Straight, Principal Chemist, OPS Peptide Science
Reviewed: May 2026
